Concepedia

Kathleen Kemmer

KK

Statistics

Publications

24

Citations

4K

H-Index

18

Active since

1992

Affiliations

Oregon Health & Science University(Current)

The University of Texas MD Anderson Cancer Center

University of Alabama at Birmingham

University of California, San Francisco

University of Pennsylvania

Kathleen Kemmer is an author at Oregon Health & Science University specializing in medicine, oncology, and breast oncology.

Publications per year

1992–2021

24

Publications

24

Effect of Pembrolizumab Plus Neoadjuvant Chemotherapy on Pathologic Complete Response in Women With Early-Stage Breast Cancer

Rita Nanda, Minetta C. Liu, Christina Yau et al. · JAMA Oncology · 2020 · 706 citations · Full text

, , +16

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

, , +15

Adaptive Randomization of Veliparib–Carboplatin Treatment in Breast Cancer

Hope S. Rugo, Olufunmilayo I. Olopade, Angela DeMichele et al. · New England Journal of Medicine · 2016 · 555 citations · Full text

, , +13

Adaptive Randomization of Neratinib in Early Breast Cancer

John W. Park, Minetta C. Liu, Douglas Yee et al. · New England Journal of Medicine · 2016 · 460 citations · Full text

, , +17

Durvalumab with olaparib and paclitaxel for high-risk HER2-negative stage II/III breast cancer: Results from the adaptively randomized I-SPY2 trial

Lajos Pusztai, Christina Yau, Denise M. Wolf et al. · Cancer Cell · 2021 · 330 citations · Full text

, , +10

1–5 of 24